136 related articles for article (PubMed ID: 14621959)
1. High glucose concentration in isotonic media alters caco-2 cell permeability.
D'Souza VM; Shertzer HG; Menon AG; Pauletti GM
AAPS PharmSci; 2003; 5(3):E24. PubMed ID: 14621959
[TBL] [Abstract][Full Text] [Related]
2. Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers.
Liu DZ; LeCluyse EL; Thakker DR
J Pharm Sci; 1999 Nov; 88(11):1161-8. PubMed ID: 10564065
[TBL] [Abstract][Full Text] [Related]
3. Extracellular glucose concentration alters functional activity of the intestinal oligopeptide transporter (PepT-1) in Caco-2 cells.
D'Souza VM; Buckley DJ; Buckley AR; Pauletti GM
J Pharm Sci; 2003 Mar; 92(3):594-603. PubMed ID: 12587121
[TBL] [Abstract][Full Text] [Related]
4. Modulation of intestinal barrier properties by miltefosine.
Menez C; Buyse M; Chacun H; Farinotti R; Barratt G
Biochem Pharmacol; 2006 Feb; 71(4):486-96. PubMed ID: 16337152
[TBL] [Abstract][Full Text] [Related]
5. [Copper treatment alters the barrier functions of human intestinal Caco-2 cells].
Liu ZW; Chen JL; Chen BH
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Nov; 38(6):406-10. PubMed ID: 15569514
[TBL] [Abstract][Full Text] [Related]
6. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
7. The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers.
Nøhr MK; Hansen SH; Brodin B; Holm R; Nielsen CU
Eur J Pharm Sci; 2014 Jan; 51():1-10. PubMed ID: 24008184
[TBL] [Abstract][Full Text] [Related]
8. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers.
Rege BD; Kao JP; Polli JE
Eur J Pharm Sci; 2002 Sep; 16(4-5):237-46. PubMed ID: 12208453
[TBL] [Abstract][Full Text] [Related]
9. Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.
Hurni MA; Noach AB; Blom-Roosemalen MC; de Boer AG; Nagelkerke JF; Breimer DD
J Pharmacol Exp Ther; 1993 Nov; 267(2):942-50. PubMed ID: 7504101
[TBL] [Abstract][Full Text] [Related]
10. Transport properties are not altered across Caco-2 cells with heightened TEER despite underlying physiological and ultrastructural changes.
Lu S; Gough AW; Bobrowski WF; Stewart BH
J Pharm Sci; 1996 Mar; 85(3):270-3. PubMed ID: 8699327
[TBL] [Abstract][Full Text] [Related]
11. Glutamine and arginine improve permeability and tight junction protein expression in methotrexate-treated Caco-2 cells.
Beutheu S; Ghouzali I; Galas L; Déchelotte P; Coëffier M
Clin Nutr; 2013 Oct; 32(5):863-9. PubMed ID: 23428392
[TBL] [Abstract][Full Text] [Related]
12. The Permeation of Acamprosate Is Predominantly Caused by Paracellular Diffusion across Caco-2 Cell Monolayers: A Paracellular Modeling Approach.
Antonescu IE; Rasmussen KF; Neuhoff S; Fretté X; Karlgren M; Bergström CAS; Nielsen CU; Steffansen B
Mol Pharm; 2019 Nov; 16(11):4636-4650. PubMed ID: 31560549
[TBL] [Abstract][Full Text] [Related]
13. Transport of decursin and decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier permeability.
Madgula VL; Avula B; Reddy V L N; Khan IA; Khan SI
Planta Med; 2007 Apr; 73(4):330-5. PubMed ID: 17372866
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of a novel Caco-2 cell perfusion system. I. In vitro prediction of the absorption potential of passively diffused compounds.
Masungi C; Borremans C; Willems B; Mensch J; Van Dijck A; Augustijns P; Brewster ME; Noppe M
J Pharm Sci; 2004 Oct; 93(10):2507-21. PubMed ID: 15349960
[TBL] [Abstract][Full Text] [Related]
15. Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers.
Hugger ED; Audus KL; Borchardt RT
J Pharm Sci; 2002 Sep; 91(9):1980-90. PubMed ID: 12210045
[TBL] [Abstract][Full Text] [Related]
16. Sucrose esters increase drug penetration, but do not inhibit p-glycoprotein in caco-2 intestinal epithelial cells.
Kiss L; Hellinger É; Pilbat AM; Kittel Á; Török Z; Füredi A; Szakács G; Veszelka S; Sipos P; Ózsvári B; Puskás LG; Vastag M; Szabó-Révész P; Deli MA
J Pharm Sci; 2014 Oct; 103(10):3107-19. PubMed ID: 25042090
[TBL] [Abstract][Full Text] [Related]
17. New and better protocols for a short-term Caco-2 cell culture system.
Yamashita S; Konishi K; Yamazaki Y; Taki Y; Sakane T; Sezaki H; Furuyama Y
J Pharm Sci; 2002 Mar; 91(3):669-79. PubMed ID: 11920752
[TBL] [Abstract][Full Text] [Related]
18. Sodium glycocholate transport across Caco-2 cell monolayers, and the enhancement of mannitol transport relative to transepithelial electrical resistance.
Lindhardt K; Bechgaard E
Int J Pharm; 2003 Feb; 252(1-2):181-6. PubMed ID: 12550793
[TBL] [Abstract][Full Text] [Related]
19. Copper treatment alters the barrier functions of human intestinal Caco-2 cells: involving tight junctions and P-glycoprotein.
Liu Z; Chen B
Hum Exp Toxicol; 2004 Aug; 23(8):369-77. PubMed ID: 15346718
[TBL] [Abstract][Full Text] [Related]
20. Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells.
Sha X; Yan G; Wu Y; Li J; Fang X
Eur J Pharm Sci; 2005 Apr; 24(5):477-86. PubMed ID: 15784337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
